JUL 25, 2015 5:46 PM PDT

The Schizophrenic Brain

WRITTEN BY: Ilene Schneider
Schizophrenia is elusive. In spite of decades of using brain scans, computer models and other sophisticated tools, there are many questions to be answered. How does it evolve? What does the brain look like when it functions abnormally? What is the relationship between structure and function? What other factors - age, disease, injury and so on - might contribute to schizophrenia?
Schizophrenia appears to be defined by structural brain abnormalities, according to the ENIGMA study.
An international team of scientists has discovered structural brain abnormalities in patients with schizophrenia, offering clues as to how the disease could develop and respond to treatment modalities. In analyzing brain MRI scans from 2,028 schizophrenia patients and 2,540 healthy controls, these scientists performed the biggest structural brain meta-analysis yet for schizophrenia. The study was conducted at more than a dozen U.S. and European locations.

Published in Molecular Psychiatry, the results come from the Schizophrenia Working Group in the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) project, which is co-chaired by Jessica Turner, associate professor of psychology and neuroscience at Georgia State, and Theo van Erp, assistant professor of psychiatry and human behavior at the University of California, Irvine (UCI). The scientists found that individuals with schizophrenia had smaller hippocampus, amygdala, thalamus, accumbens and intracranial volumes than control participants. They also determined that people with schizophrenia had larger pallidum and ventricle volumes than the controls. These brain areas are responsible for memory, emotion and reward.

ENIGMA, which started in 2009, brings together brain researchers from 33 countries to study the brain. The organization's purpose is to share the huge amounts of brain scan data that are too big for one scientist to analyze alone and examine them to determine which genes or medications influence neurodegenerative and severe mental illnesses. The ENIGMA project collaborations include working groups for other mental disorders such as major depression, ADHD, autism, bipolar disorder and addiction.

Van Erp, who earned his Ph.D. from the University of Utrecht in Utrecht, The Netherlands, in 2007, stated that the next steps are to compare structural data across disorders to identify which brain region is most affected in each and to determine the effects of various factors. As he said, "This collaborative work of 58 researchers marks a new era of open team science in applying neuroimaging methods to address questions in severe mental illness, such as schizophrenia," van Erp said.

Van Erp added that the next step is to compare structural data across disorders to identify which brain region is the most affected in which disorder, to determine the effects of genetic variation, environmental factors, age and medication and the similarities in symptoms between disorders. "Ultimately, our advances in knowledge must lead to better treatment outcomes for patients, their families, and society as a whole," he said.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
AUG 25, 2020
Neuroscience
Fear of Germs Leading Factor in COVID-19 Preventative Behavior
AUG 25, 2020
Fear of Germs Leading Factor in COVID-19 Preventative Behavior
Researchers from the University of Connecticut have found that people with a psychological aversion to germs are more li ...
SEP 08, 2020
Neuroscience
Thyroid Inflammation Linked to Anxiety Disorder
SEP 08, 2020
Thyroid Inflammation Linked to Anxiety Disorder
Findings from a new study suggest that people with autoimmune inflammation in their thyroid may be more likely to develo ...
SEP 08, 2020
Neuroscience
Synchronizing Brain Waves Could Help Dyslexia Effects
SEP 08, 2020
Synchronizing Brain Waves Could Help Dyslexia Effects
New research from the University of Geneva shows that adults with dyslexia can read more fluently with a non-invasive el ...
OCT 20, 2020
Neuroscience
Negative Behavior Triggers Same Brain Patterns as Bad Smells
OCT 20, 2020
Negative Behavior Triggers Same Brain Patterns as Bad Smells
Researchers from the University of Geneva have found that witnessing negative behaviors triggers similar neural response ...
NOV 07, 2020
Cannabis Sciences
Does Cannabis Make Bipolar Disorder Better or Worse?
NOV 07, 2020
Does Cannabis Make Bipolar Disorder Better or Worse?
While anecdotal evidence and some case studies suggest cannabis may benefit those with bipolar disorder, studies have re ...
NOV 18, 2020
Clinical & Molecular DX
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
NOV 18, 2020
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disor ...
Loading Comments...